Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): A prospective cross-sectional observational study

The Lancet Global Health

Volumn 3, Issue 1, 2015, Pages e44-e51

  Van Gemert, Frederik ^a   Kirenga, Bruce ^b   Chavannes, Niels ^c   Kamya, Moses ^b   Luzige, Simon ^b   Musinguzi, Patrick ^b   Turyagaruka, John ^d   Jones, Rupert ^e   Tsiligianni, Ioanna ^a   Williams, Sian ^f   de Jong, Corina ^a   van der Molen, Thys ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAKERERE UNIVERSITY   (Uganda)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d District Health Office   (Uganda)

^e UNIVERSITY OF PLYMOUTH   (United Kingdom)

^f International Primary Care Respiratory Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; TOBACCO SMOKE; SMOKE;

ADULT; AGE; AGED; AGRICULTURAL WORKER; ARTICLE; ASTHMA; BODY HEIGHT; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; COUGHING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG DELIVERY DEVICE; DYSPNEA; ELECTRICITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEALTH CARE PERSONNEL; HEART FAILURE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NURSE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; REDIHALER; RISK FACTOR; RURAL AREA; SMOKING; SPIROMETRY; TUBERCULOSIS; UGANDA; VERY ELDERLY; WHEEZING; ABNORMAL RESPIRATORY SOUND; BIOMASS; HEALTH; MIDDLE AGED; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SMOKE; VITAL CAPACITY;

ADULT; AGED; BIOMASS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY SOUNDS; RISK FACTORS; RURAL HEALTH; SMOKE; SMOKING; SPIROMETRY; UGANDA; VITAL CAPACITY;

EID: 84919484580     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70337-7     Document Type: Article

References (35)

1. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
2. Global surveillance, prevention and control of Chronic Respiratory Diseases: a comprehensive approach 2007, WHO, World Health Organization, Geneva.
3. Mannino M, Buist AS Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765-773.
4. World Health Statistics 2008, WHO, World Health Organization, Geneva.
5. Respiratory diseases in the world: reality of today - opportunities for tomorrow Forum of International Respiratory Societies, (accessed Nov 25, 2014). http://www.ersnet.org/images/firs-world-report.pdf.
6. Global strategy for diagnosis, management and prevention of COPD Global Initiative for Chronic Obstructive Lung Disease, (accessed Nov 25, 2014). http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
7. Kurmi OP, Lam KB, Ayres JG Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012, 40:239-254.
8. Perez-Padilla R, Schilmann A, Riojas-Rodriguez H Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis 2010, 14:1079-1086.
9. Salvi S, Barnes PJ Is exposure to biomass smoke the biggest risk factor for COPD globally?. Chest 2010, 138:3-6.
10. van Gemert F, van der Molen T, Jones R, Chavannes N The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J 2011, 20:240-248.
11. van Gemert F, Chavannes N, Nabadda N, et al. Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J 2013, 22:300-305.
12. Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis 2013, 17:583-589.
13. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
14. Musafiri S, van Meerbeeck J, Musango L, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med 2011, 105:1596-1605.
15. Male-Mukasa JB Uganda National Household Survey 2010, Uganda Bureau of Statistics.
16. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
17. Burney PG, Laitinen LA, Perdrizet S, et al. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J 1989, 2:940-945.
18. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006, 73:285-295.
19. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006, 73:296-305.
20. Bakke PS, Ronmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J 2011, 38:1261-1277.
21. Price D, Crockett A, Arne M, et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J 2009, 18:216-223.
22. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968.
23. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012, 40:1324-1343. the ERS Global Lung Function Initiative.
24. Stanojevic S, Wade A, Stocks J Reference values for lung function: past, present and future. Eur Respir J 2010, 36:12-19.
25. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 28:13.
26. Armitage P, Berry G, Matthews JNS Statistical methods in medical research 2002, Blackwell Science. Fourth edn.
27. Apple J, Vicente R, Yarberry A, et al. Characterization of particulate matter size distributions and indoor concentrations from kerosene and diesel lamps. Indoor Air 2010, 20:399-411.
28. Lam NL, Smith KR, Gauthier A, Bates MN Kerosene: a review of household uses and their hazards in low- and middle-income countries. J Toxicol Environ Health B Crit Rev 2012, 15:396-432.
29. Menezes AMB, Perez-Padilla R, Hallal PC, et al. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis 2008, 12:709-712.
30. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993, 16(suppl):5-40.
31. Masoli M, Fabian D, Holt S, Beasley R The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59:469-478.
32. Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009, 64:476-483.
33. Wjst M, Boakye D Asthma in Africa. PLoS Med 2007, 4:e72.
34. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011, 139:52-59.
35. Stocks J, Baur X, Hall G, Culver B Implementation GLI 2012 regression equations (accessed Nov 25, 2014). http://www.lungfunction.org/files/implementingGLIequations.pdf.